Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megace for Atypical Endometrial Hyperplasia and Endometrial Carcinoma
NCT00483327Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2007
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of megestrol in Atypical endometrial hyperplasia (AEH), endometrial carcinoma, sponsored by NYU Langone Health. Started Jun 2007; status: completed.
02
Drugs
megestrol
03
Conditions
Atypical endometrial hyperplasia (AEH)endometrial carcinoma
Beyond the preview
Go deeper on NCT00483327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483327.